Oral formulation containing dimethylglycine to improve the condition of hair and scalp.
DE502023003096D1Active Publication Date: 2026-03-12DR KURT WOLFF
0 Cites 0 Cited by
Patent Information
- Application Number
- DE502023003096
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2022-04-06
- Filing Date
- 2023-04-06
- Publication Date
- 2026-03-12
- Estimated Expiration
- 2043-04-06
AI Technical Summary
Technical Problem
Current treatments for hair loss, particularly androgenetic alopecia and alopecia areata, are either ineffective or come with unpleasant side effects, and there is a lack of evidence on suitable micronutrient supplementation for individuals without nutrient deficiencies.
Method used
An oral composition containing dimethylglycine and/or its salts in combination with amylopectin, where the ratio of amylopectin to amylose is 0.9 to 1.0, promoting nutrient and oxygen supply to the scalp and hair roots, thereby addressing hair loss.
Benefits of technology
The composition effectively treats and prevents hair loss by enhancing scalp activity and hair root strength with minimal side effects, improving hair density and root activity.
✦ Generated by Eureka AI based on patent content.
Need to check novelty before this filing date? Find Prior Art
No text content released.